"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 6 | 6 |
| 1997 | 0 | 11 | 11 |
| 1998 | 0 | 18 | 18 |
| 1999 | 0 | 27 | 27 |
| 2000 | 0 | 21 | 21 |
| 2001 | 0 | 29 | 29 |
| 2002 | 0 | 24 | 24 |
| 2003 | 0 | 47 | 47 |
| 2004 | 0 | 33 | 33 |
| 2005 | 0 | 42 | 42 |
| 2006 | 0 | 43 | 43 |
| 2007 | 0 | 52 | 52 |
| 2008 | 0 | 45 | 45 |
| 2009 | 3 | 45 | 48 |
| 2010 | 3 | 61 | 64 |
| 2011 | 9 | 54 | 63 |
| 2012 | 5 | 64 | 69 |
| 2013 | 4 | 65 | 69 |
| 2014 | 6 | 63 | 69 |
| 2015 | 9 | 83 | 92 |
| 2016 | 5 | 65 | 70 |
| 2017 | 8 | 77 | 85 |
| 2018 | 6 | 85 | 91 |
| 2019 | 10 | 94 | 104 |
| 2020 | 5 | 79 | 84 |
| 2021 | 5 | 63 | 68 |
| 2022 | 0 | 39 | 39 |
| 2023 | 0 | 41 | 41 |
| 2024 | 19 | 29 | 48 |
| 2025 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2. Br J Ophthalmol. 2025 Feb 24; 109(3):401-407.
-
Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. Neurology. 2025 Feb 25; 104(4):e210213.
-
Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2025 Feb; 211(2):157-173.
-
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study. Ann Rheum Dis. 2025 Feb; 84(2):201-209.
-
The Roles of Myeloid Cells in Breast Cancer Progression. Adv Exp Med Biol. 2025; 1464:397-412.
-
Dynamic and concordance-assisted learning for risk stratification with application to Alzheimer's disease. Biostatistics. 2024 Dec 31; 26(1).
-
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data. Parkinsonism Relat Disord. 2025 Mar; 132:107257.
-
Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. 2024 Dec 21; 161(1):53.
-
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial. J Clin Oncol. 2025 Mar 20; 43(9):1101-1112.
-
Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study. Clin Cancer Res. 2024 Dec 16; 30(24):5559-5567.